(Q39268019)

10 September 2017

title

Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways (English)

1 reference

10 September 2017

main subject

reactive oxygen species

1 reference

Jian Ma

1

1 reference

10 September 2017

Yanpeng Wang

2

1 reference

10 September 2017

Dong Zheng

3

1 reference

10 September 2017

Meng Wei

4

1 reference

10 September 2017

Huaxi Xu

5

1 reference

10 September 2017

Tianqing Peng

6

1 reference

10 September 2017

publication date

1 October 2012

1 reference

10 September 2017

published in

Cardiovascular Research

1 reference

10 September 2017

volume

97

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

77-87

1 reference

Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Role of anthracyclines in the era of targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Significance of adaptation mechanisms in adriamycin induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Doxorubicin cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Molecular composition and regulation of the Nox family NAD(P)H oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Regulation of NADPH oxidases: the role of Rac proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Histone deacetylase: a regulator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Histone deacetylases specifically down-regulate p53-dependent gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Rac1 is required for cardiomyocyte apoptosis during hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

DNA double-strand breaks and gamma-H2AX signaling in the testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Requirement of Rac1 in the development of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Redox modulation of p53: mechanisms and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

H2AX is a target of the JNK signaling pathway that is required for apoptotic DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

p300/CBP/p53 interaction and regulation of the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS309

21 January 2018

Identifiers

DOI

10.1093/CVR/CVS309

1 reference

10 September 2017

1 reference